Institute of Biomedical Research Corpの主要な財務諸表は何ですか?
MRESの主要な財務比率は何ですか?
Institute of Biomedical Research Corpの収益はセグメントまたは地域別にどのように分けられていますか?
Institute of Biomedical Research Corpは収益を上げていますか?
Institute of Biomedical Research Corpに負債はありますか?
Institute of Biomedical Research Corpの発行済株式数は何株ですか?
主要データ
前終値
$0.002
始値
$0.002
当日レンジ
$0.002 - $0.002
52週レンジ
$0.0016 - $0.0241
取引高
1.2K
平均取引高
962.1K
1株当たり利益(TTM)
--
配当利回り
--
時価総額
$4.7M
MRESとは何ですか?
Institute of BioMedical Research Corp. engages in research and development, quality control and standardization of pharmaceuticals, cosmetics and food products. The company is headquartered in Niksic, Niksic. The company went IPO on 2000-10-27. The firm's services include scientific research and biomedical services, such as research and development, quality control, standardization of pharmaceuticals, cosmetics and food products. The firm also provides long-term biomedical and environmental research projects, develops new diagnostic biomedical technologies and experimental medical treatments. The firm's products include Aerosan, MicrobEX, Microbicidal Towels KleNET, OralNet, Oral Ocean Power and Purilair. The company offers electro medical devices, such as BioMed 2000 XT with Timer, BioStim INF, QuadStar Elite, QuadStar II, Pain Gone piezo-electric pain relief and Portable Ultra Sound Device. The company offers various services, including quality control services, regulatory services, healthcare services, environmental analyses, building decontamination, and environmental protection and management.